Solutions for the Biopharma-Industry
I have strong empathy for the rising number of MD and/or PhD graduates who are eager to start their own biotech company with a great idea or invention made during their studies. This, of course, extends to spin-offs from big pharma as well. For such start-ups my partners and I take care of everything from defining a sound equity story, advising them to focus on the most promising AND most realistic projects, helping them with the financing, and accompanying and supporting them in all strategic questions. Right from the start we take on crisis management because we know the many pitfalls in any medical-scientific product and project development.
We also focus on clients from big listed biopharma companies. After 10 years of working as a physician, medical investigator, and senior scientist in basic and clinical-oriented research, and with 20 years international working experience as Biotech fund manager and Pharma/Biotech analyst, I have collected a lot of insights. Therefore, I am able to offer convincing solutions for strategic communications to streamline the expectations of all stakeholders such as investors, analysts, licence holders etc. and the company itself, to maintain a healthy balance in their working relationship.
Services
We cover a broad spectrum of essential services to assist you with a successful start-up and a continued progress of your biopharma business.
THE
equity story
To create a sound equity story and an easily understandable corporate message, as brilliant ideas need to be communicated effectively.
THE
humble strategy
To focus on your core competency and a good strategy; avoiding overconfidence and empty promises.
THE
financing
To always give preference to academic grants, institutional investors and venture capital companies specialized in healthcare, which will at the same time be a form of validation.
THE
market awareness
We convince the market of the potential of the project. As such the market is not patient and in times of uncertainty investors may shy away from risky investments, especially in the biotech field.
THE
ongoing companion
Once a specific strategy, operational measures and communications have been agreed upon, we will continue our support and provide long-term business development assistance.
THE
crisis management
We all know how unpredictable outcomes of medical-scientific research and development are, where even minor delays will have a negative impact. We provide support to navigate you through difficult periods.